WALGREENS BOOTS ALLIANCE, INC. (NASDAQ:WBA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

On April19, 2017, the Board of Directors (the Board) of Walgreens
Boots Alliance, Inc. (the Company), upon the recommendation of
the Nominating and Governance Committee, elected Jos E. Almeida
to the Board effective immediately for a term continuing to the
Companys next Annual Meeting of Stockholders on January17, 2018,
when Mr.Almeida will be subject to election by stockholders. The
Board also appointed Mr.Almeida to serve on the Compensation
Committee and Nominating and Governance Committee of the Board.

Mr.Almeida has served as the Chairman of the Board and Chief
Executive Officer of Baxter International Inc. (Baxter), a global
medical products company, since January 2016. He began serving as
an executive officer of Baxter in October 2015, having served as
an operating executive with The Carlyle Group from May 2015 to
October 2015. He served as the Chairman, President and Chief
Executive Officer of Covidien plc (Covidien) from March 2012 to
January 2015 prior to Medtronic Inc.s acquisition of Covidien;
and as President and Chief Executive Officer of Covidien from
July 2011 to March 2012. He served in several executive roles at
Covidien (formerly Tyco Healthcare) between April 2004 and June
2011. Mr.Almeida served on the board of directors of State Street
Corporation from October 2013 to November 2015, Analog Devices,
Inc. from December 2014 to November 2015 and EMC Corporation from
January 2015 to November 2015.

There were no arrangements or understandings to which Mr.Almeida
was appointed to the Board, and since the beginning of the last
fiscal year, there have been no related party transactions
between the Company and Mr.Almeida that would be reportable under
Item404(a) of Regulation S-K. Mr.Almeidas compensation for
service as a non-employee director will be consistent with that
of the Companys other non-employee directors, subject to
proration to reflect the commencement date of his service on the
Board. The non-employee director compensation program is
described under the caption Director Compensation in the Companys
definitive proxy statement for its January26, 2017 Annual Meeting
of Stockholders filed with the Securities and Exchange Commission
on December8, 2016.

Item8.01 Other Events.

On April19, 2017, the Company issued a press release announcing
the election of Mr.Almeida to the Board. A copy of the press
release is attached as Exhibit 99.1 hereto and incorporated in
this Item8.01 by reference.

Item9.01 Financial Statements and
Exhibits.

About WALGREENS BOOTS ALLIANCE, INC. (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.

WALGREENS BOOTS ALLIANCE, INC. (NASDAQ:WBA) Recent Trading Information

WALGREENS BOOTS ALLIANCE, INC. (NASDAQ:WBA) closed its last trading session up +0.69 at 83.51 with 2,894,280 shares trading hands.